AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®
Wound Closure in Venous Leg Ulcers (VLUs) Treated With AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®: A Blinded Re-Assessment of Randomized Controlled Trial Findings
1 other identifier
observational
105
1 country
1
Brief Summary
Study is to provide a blinded assessment of wound closure status utilizing photographs collected as per standard of care (SOC) during the AAA RCT (WC-22-435).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2025
CompletedFirst Submitted
Initial submission to the registry
December 17, 2025
CompletedFirst Posted
Study publicly available on registry
December 30, 2025
CompletedJanuary 8, 2026
January 1, 2026
1 month
December 17, 2025
January 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Wound closure at 12 weeks
Incidence of wound closure at 12 weeks, defined as 100% epithelialization of the wound surface, assessed by a blinded observer through photographic evidence
12 week
Other Outcomes (2)
Inter-rater reliability of photographic assessment
up to 12 week
Inter-rater reliability of photographic site assessment
up to 12 week
Eligibility Criteria
Subjects who have wound photographs of sufficient quality taken as per standard of care (SOC) during the AAA RCT (WC-22-435) that correspond to wound closure or their 12-week visit.
You may qualify if:
- All subjects from the intention to treat (ITT) population with wound photograph(s) corresponding to the study visit date (WC-22-435) indicating wound closure or their 12-week visit, whichever came first
You may not qualify if:
- Subjects whose photographs are deemed of insufficient quality to make determination of closure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ConvaTec Inc.lead
Study Sites (1)
Essen University Hospital
Essen, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joachim Dissemond, MD
Essen University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2025
First Posted
December 30, 2025
Study Start
April 22, 2025
Primary Completion
May 28, 2025
Study Completion
May 28, 2025
Last Updated
January 8, 2026
Record last verified: 2026-01